Abstract
Although persistence of postoperative risk of death beyond 30 days has been demonstrated in coronary artery bypass grafting,1 this has not been investigated well in patients who underwent mitral valve (MV) surgeries. Increasing attention to outcomes beyond 30-days as a quality metric is evident through federally funded programs, such as the Hospital Readmission Reduction Program2 and the newly developed reimbursement scheme to incentivize coordination of postacute phase of care.3 To inform such initiatives for patients undergoing MV operations, we aimed to characterize temporal change in the risk of death within 1 year after MV repair and MV replacement (MVR).
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
